• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Holdings
Company Encyclopedia
View More
name
CSI Yangtze River Delta Area Development Theme ETF
512650.SH
Shareholder
Ownership%OwnedShare ChgReport Date
No Data
News
View More

Zhejiang Sanhua Announces Extraordinary General Meeting for Key Resolutions

Zhejiang Sanhua Intelligent Controls Co., Ltd. has announced an extraordinary general meeting on November 27, 2025, to discuss key resolutions including amendments to the Articles of Association, changes to corporate governance, and the 2025 half-year profit distribution plan. This meeting is significant for the company's governance and financial strategies, potentially affecting shareholder interests. The stock currently has a Buy rating with a price target of HK$43.10 and a market cap of HK$188B.

Tip Ranks·Yesterday at 17:41
SZ
002050
-3.85%
Tip Ranks·Yesterday at 17:41
SZ
002050
-3.85%

Zhejiang Sanhua Updates Interim Dividend Details for 2025

Zhejiang Sanhua Intelligent Controls Co., Ltd. (HK:2050) has announced an interim cash dividend of RMB 1.2 per 10 shares for the six months ending June 30, 2025. Key dates include shareholder approval on November 27, 2025, and an ex-dividend date of December 4, 2025. This reflects the company's commitment to shareholder value. The latest analyst rating for the stock is a Buy with a price target of HK$43.10. The company specializes in HVAC and refrigeration components and has a market cap of HK$188B.

Tip Ranks·Yesterday at 17:41
SZ
002050
-3.85%
Tip Ranks·Yesterday at 17:41
SZ
002050
-3.85%

Event Tracking

Nov7
Hengrui Medicine's Subsidiary Obtains Clinical Trial Approval for SHR-4610 Injection
09:43
Bank of Communications Launches Fintech Solutions to Facilitate Cross-border Payments and Trade
04:42
Nov6
Innovation and Enhancement of Sci-Tech Finance Business in Anhui Branch of Bank of Communications
22:17
Wellington Management Increases Holdings in Hengrui Medicine by 855,600 Shares
13:18
WuXi AppTec Optimizes Global Capacity Layout, Building Global Supply Chain Network
00:42
Nov5
Hengrui Medicine Announces Clinical Trial Results of GLP-1/GIP Dual Receptor Agonist HRS9531 and Submits New Drug Application
00:06
Terms & Conditions
  • Terms of Service
  • Privacy Policy